BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28183295)

  • 1. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.
    Chow YP; Alias H; Jamal R
    BMC Cancer; 2017 Feb; 17(1):120. PubMed ID: 28183295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis of gene expression profiles in childhood B-precursor acute lymphoblastic leukemia.
    Li J; Zhai X; Wang H; Qian X; Miao H; Zhu X
    Hematology; 2015 Aug; 20(7):377-83. PubMed ID: 25431969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
    Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
    Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse.
    Núñez-Enríquez JC; Bárcenas-López DA; Hidalgo-Miranda A; Jiménez-Hernández E; Bekker-Méndez VC; Flores-Lujano J; Solis-Labastida KA; Martínez-Morales GB; Sánchez-Muñoz F; Espinoza-Hernández LE; Velázquez-Aviña MM; Merino-Pasaye LE; García Velázquez AJ; Pérez-Saldívar ML; Mojica-Espinoza R; Ramírez-Bello J; Jiménez-Morales S; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):644-655. PubMed ID: 28476192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.
    Staal FJ; van der Burg M; Wessels LF; Barendregt BH; Baert MR; van den Burg CM; van Huffel C; Langerak AW; van der Velden VH; Reinders MJ; van Dongen JJ
    Leukemia; 2003 Jul; 17(7):1324-32. PubMed ID: 12835720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses.
    Szczepanek J; Styczyński J; Haus O; Tretyn A; Wysocki M
    Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):61-8. PubMed ID: 21246408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration.
    Ouimet M; Drouin S; Lajoie M; Caron M; St-Onge P; Gioia R; Richer C; Sinnett D
    Oncotarget; 2017 Jan; 8(5):7477-7488. PubMed ID: 27980230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
    Haouas H; Haouas S; Uzan G; Hafsia A
    Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of IRF4 aberrant gene expression in the acute leukemias of childhood.
    Adamaki M; Lambrou GI; Athanasiadou A; Tzanoudaki M; Vlahopoulos S; Moschovi M
    PLoS One; 2013; 8(8):e72326. PubMed ID: 23977280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide excision repair is a predictor of early relapse in pediatric acute lymphoblastic leukemia.
    Ibrahim OM; As Sobeai HM; Grant SG; Latimer JJ
    BMC Med Genomics; 2018 Oct; 11(1):95. PubMed ID: 30376844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
    Krentz S; Hof J; Mendioroz A; Vaggopoulou R; Dörge P; Lottaz C; Engelmann JC; Groeneveld TW; Körner G; Seeger K; Hagemeier C; Henze G; Eckert C; von Stackelberg A; Kirschner-Schwabe R
    Leukemia; 2013 Feb; 27(2):295-304. PubMed ID: 22699455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents.
    Suzuki K; Okuno Y; Kawashima N; Muramatsu H; Okuno T; Wang X; Kataoka S; Sekiya Y; Hamada M; Murakami N; Kojima D; Narita K; Narita A; Sakaguchi H; Sakaguchi K; Yoshida N; Nishio N; Hama A; Takahashi Y; Kudo K; Kato K; Kojima S
    J Clin Oncol; 2016 Oct; 34(28):3451-9. PubMed ID: 27507882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
    Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H
    Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.
    Mullighan CG; Phillips LA; Su X; Ma J; Miller CB; Shurtleff SA; Downing JR
    Science; 2008 Nov; 322(5906):1377-80. PubMed ID: 19039135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics.
    Wang SJ; Wang PZ; Gale RP; Qin YZ; Liu YR; Lai YY; Jiang H; Jiang Q; Zhang XH; Jiang B; Xu LP; Huang XJ; Liu KY; Ruan GR
    Oncotarget; 2017 May; 8(22):35984-36000. PubMed ID: 28415593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
    Mullighan CG
    Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia.
    Folgiero V; Sorino C; Pallocca M; De Nicola F; Goeman F; Bertaina V; Strocchio L; Romania P; Pitisci A; Iezzi S; Catena V; Bruno T; Strimpakos G; Passananti C; Mattei E; Blandino G; Locatelli F; Fanciulli M
    EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29367285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIF11 serves as a cell cycle mediator in childhood acute lymphoblastic leukemia.
    Zhu L; Chen C; Kang M; Ma X; Sun X; Xue Y; Fang Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15609-15622. PubMed ID: 37656243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormally high expression of POLD1, MCM2, and PLK4 promotes relapse of acute lymphoblastic leukemia.
    Li S; Wang C; Wang W; Liu W; Zhang G
    Medicine (Baltimore); 2018 May; 97(20):e10734. PubMed ID: 29768346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.